Literature DB >> 16380527

Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study.

Giovanni de Simone1, Richard B Devereux, Marcello Chinali, Mary J Roman, Lyle G Best, Thomas K Welty, Elisa T Lee, Barbara V Howard.   

Abstract

Whether metabolic factors and their change over time influence development of arterial hypertension in adults with initially optimal blood pressure (BP) is unknown. We analyzed associations of BP in the optimal range (<120/80 mm Hg), metabolic risk factors, and their changes over 4-year follow-up, with 8-year incident hypertension, in a cohort of American Indians with a high prevalence of obesity. At baseline, 967 participants with optimal BP and no prevalent cardiovascular disease (69.5% women; mean age, 54+/-7 years) were evaluated and reexamined after 4 (second examination) and 8 years to evaluate predictors of 8-year incident arterial hypertension. In participants with normal glucose tolerance, baseline BP and decrease in high-density lipoprotein cholesterol from baseline to the second examination were the most potent predictors of 8-year arterial hypertension (both P<0.0001), with additional effects of baseline waist circumference and its increase, increase in BP, and presence of diabetes at the second examination (all P<0.04). In participants with impaired glucose tolerance or diabetes, the most potent predictor of 8-year incident hypertension was diabetes at the second examination (P<0.0001) followed by a increase in BP and LDL cholesterol over the first 4 years (both P<0.001). Thus, incident arterial hypertension can be predicted by initial metabolic profile and unfavorable metabolic variations over time, in addition to initial BP. At optimal levels of initial BP, increasing abdominal obesity, and abnormal lipid profile are major predictors of development of arterial hypertension. Possible implications of these findings for primary cardiovascular prevention should be tested in prospective studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380527     DOI: 10.1161/01.HYP.0000199103.40105.b5

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

1.  Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.

Authors:  Ian H de Boer; Bryan Kestenbaum; Tessa C Rue; Michael W Steffes; Patricia A Cleary; Mark E Molitch; John M Lachin; Noel S Weiss; John D Brunzell
Journal:  Arch Intern Med       Date:  2008-09-22

2.  Lipoprotein-associated phospholipase A2 is associated with postpartum hypertension in women with history of preeclampsia.

Authors:  Yuheng Zhou; Jianmin Niu; Dongmei Duan; Qiong Lei; Jiying Wen; Xiaohong Lin; Lijuan Lv; Longding Chen
Journal:  Heart Vessels       Date:  2014-04-23       Impact factor: 2.037

Review 3.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

Review 4.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

5.  Lipoprotein subclass abnormalities and incident hypertension in initially healthy women.

Authors:  Nina P Paynter; Howard D Sesso; David Conen; James D Otvos; Samia Mora
Journal:  Clin Chem       Date:  2011-06-23       Impact factor: 8.327

6.  Cholesterol affects flow-stimulated cyclooxygenase-2 expression and prostanoid secretion in the cortical collecting duct.

Authors:  Yu Liu; Daniel Flores; Rolando Carrisoza-Gaytán; Rajeev Rohatgi
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-11

7.  Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Mary J Roman; Thomas K Welty; Elisa T Lee; Barbara V Howard
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

Review 8.  Does it matter how you lower blood pressure in patients with uncomplicated hypertension? Weighing the evidence.

Authors:  Daniel A Duprez
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

9.  Prediction of incident hypertension risk in women with currently normal blood pressure.

Authors:  Nina P Paynter; Nancy R Cook; Brendan M Everett; Howard D Sesso; Julie E Buring; Paul M Ridker
Journal:  Am J Med       Date:  2009-05       Impact factor: 4.965

10.  Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy.

Authors:  Katherine Krauskopf; Mark L Van Natta; Ronald P Danis; Sapna Gangaputra; Lori Ackatz; Adrienne Addessi; Alex D Federman; Andrea D Branch; Curtis L Meinert; Douglas A Jabs
Journal:  J Int Assoc Provid AIDS Care       Date:  2013 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.